These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35787822)

  • 1. Subcranial Midface Advancement in Patients with Syndromic Craniosynostosis.
    Massenburg BB; Susarla SM; Kapadia HP; Hopper RA
    Oral Maxillofac Surg Clin North Am; 2022 Aug; 34(3):467-475. PubMed ID: 35787822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications in 54 frontofacial distraction procedures in patients with syndromic craniosynostosis.
    Goldstein JA; Paliga JT; Taylor JA; Bartlett SP
    J Craniofac Surg; 2015 Jan; 26(1):124-8. PubMed ID: 25569391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual midfacial distraction osteogenesis: Le Fort III minus I and Le Fort I for syndromic craniosynostosis.
    Satoh K; Mitsukawa N; Hosaka Y
    Plast Reconstr Surg; 2003 Mar; 111(3):1019-28. PubMed ID: 12621171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Craniofacial Stability in Patients With Crouzon or Apert Syndrome After Le Fort III Distraction Osteogenesis.
    Reitsma JH; Ongkosuwito EM; Buschang PH; Adrichem LN; Prahl-Andersen B
    Cleft Palate Craniofac J; 2013 Sep; 50(5):561-9. PubMed ID: 22909221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Le Fort III osteotomy: to distract or not to distract?
    Fearon JA
    Plast Reconstr Surg; 2001 Apr; 107(5):1091-103; discussion 1104-6. PubMed ID: 11373547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-Year Follow-Up of Midface Distraction in Growing Children with Syndromic Craniosynostosis.
    Patel PA; Shetye P; Warren SM; Grayson BH; McCarthy JG
    Plast Reconstr Surg; 2017 Dec; 140(6):794e-803e. PubMed ID: 28820838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthognathic Surgery in Patients with Syndromic Craniosynostosis.
    Han JT; Egbert MA; Ettinger RE; Kapadia HP; Susarla SM
    Oral Maxillofac Surg Clin North Am; 2022 Aug; 34(3):477-487. PubMed ID: 35787829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 10-year study of skeletal stability and growth of the midface following Le Fort III advancement in syndromic craniosynostosis.
    Shetye PR; Kapadia H; Grayson BH; McCarthy JG
    Plast Reconstr Surg; 2010 Sep; 126(3):973-981. PubMed ID: 20463620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinasal Osteotomy With Distraction Osteogenesis for a Mild Syndromic Craniosynostosis.
    Kobayashi S; Fukawa T; Yasumura K; Satake T; Maegawa J
    J Craniofac Surg; 2019 Jan; 30(1):50-52. PubMed ID: 30418289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Le Fort IV + I distraction osteogenesis using an internal device for syndromic craniosynostosis.
    Sakamoto Y; Nakajima H; Tamada I; Sakamoto T
    J Oral Maxillofac Surg; 2014 Apr; 72(4):788-95. PubMed ID: 24280175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional computed tomographic evaluation of Le Fort III distraction osteogenesis with an external device in syndromic craniosynostosis.
    Wery MF; Nada RM; van der Meulen JJ; Wolvius EB; Ongkosuwito EM
    Br J Oral Maxillofac Surg; 2015 Mar; 53(3):285-91. PubMed ID: 25605236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Le Fort III external midface distraction: surgical outcomes and skeletal stability.
    Iannetti G; Ramieri V; Pagnoni M; Fadda MT; Cascone P
    J Craniofac Surg; 2012 May; 23(3):896-900. PubMed ID: 22565921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical-Orthodontic Considerations in Subcranial and Frontofacial Distraction.
    Hopper RA; Kapadia H; Susarla SM
    Oral Maxillofac Surg Clin North Am; 2020 May; 32(2):309-320. PubMed ID: 32102742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Le Fort II Distraction with Simultaneous Zygomatic Repositioning.
    Hopper RA; Wang HD; Mercan E
    Clin Plast Surg; 2021 Jul; 48(3):487-496. PubMed ID: 34051900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midface correction in patients with Crouzon syndrome is Le Fort III distraction osteogenesis with a rigid external distraction device the gold standard?
    Engel M; Berger M; Hoffmann J; Kühle R; Rückschloss T; Ristow O; Freudlsperger C; Kansy K
    J Craniomaxillofac Surg; 2019 Mar; 47(3):420-430. PubMed ID: 30642732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subcranial Le Fort III advancement with distraction osteogenesis as a clinical strategy to approach pycnodysostosis with midface retrusion and exorbitism.
    Raposo-Amaral CE; Tong A; Denadai R; Yalom A; Raposo-Amaral CA; Bertola D; Li A; Jarrahy R
    J Craniofac Surg; 2013 Jul; 24(4):1327-30. PubMed ID: 23851800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving differential facial changes with Le Fort III distraction osteogenesis: the use of nasal passenger grafts, cerclage hinges, and segmental movements.
    Hopper RA; Prucz RB; Iamphongsai S
    Plast Reconstr Surg; 2012 Dec; 130(6):1281-1288. PubMed ID: 22878478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Le Fort III distraction osteogenesis versus conventional Le Fort III osteotomy in correction of syndromic midfacial hypoplasia: a systematic review.
    Saltaji H; Altalibi M; Major MP; Al-Nuaimi MH; Tabbaa S; Major PW; Flores-Mir C
    J Oral Maxillofac Surg; 2014 May; 72(5):959-72. PubMed ID: 24280172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midface distraction following Le Fort III and monobloc osteotomies: problems and solutions.
    Gosain AK; Santoro TD; Havlik RJ; Cohen SR; Holmes RE
    Plast Reconstr Surg; 2002 May; 109(6):1797-808. PubMed ID: 11994576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term evaluation of midface position after Le Fort III advancement: a 20-plus-year follow-up.
    Warren SM; Shetye PR; Obaid SI; Grayson BH; McCarthy JG
    Plast Reconstr Surg; 2012 Jan; 129(1):234-242. PubMed ID: 22186512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.